| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |